CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

CVS HEALTH Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$92.68+0.32 (+0.35%)

Close on Oct 19, 2026

Market cap: $119.28B
P/E (TTM): 24.6
Dividend yield: 2.87%

CVS HEALTH Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-29
Revenue	402,067	372,809	357,776	322,467	292,111	268,706	256,776	194,579	184,786	177,546	153,290	139,367	126,761	123,120	107,080	95,778	98,215	87,472	76,330
Cost of Revenue	221,167	206,287	217,098	196,892	175,803	163,981	158,719	156,447	153,448	146,533	126,762	114,000	102,978	100,632	86,518	75,559	77,857	69,182	60,222
Gross Profit	180,900	166,522	140,678	125,575	116,308	104,725	98,057	38,132	28,545	28,857	26,528	25,367	23,783	22,488	20,562	20,219	20,358	18,290	16,108
Advertising Expenses	970	989	985	745	707	613	396	364	230	216	221	212	177	221	211	234	317	324	–
Operating Expenses	–	–	–	–	–	–	33,541	21,368	18,809	18,448	17,053	16,568	15,746	15,278	14,231	14,082	13,933	12,244	11,314
Total Costs & Expenses	397,407	364,293	344,033	314,513	278,801	254,795	244,789	190,558	175,248	167,160	–	–	–	–	–	–	–	–	–
Operating Income	4,660	8,516	13,743	7,954	13,310	13,911	11,987	4,021	9,538	10,386	9,475	8,799	8,037	7,210	6,331	6,137	6,425	6,046	4,794
Interest Expense	3,119	2,958	2,658	2,287	2,503	2,907	3,035	2,619	1,062	1,078	859	615	517	561	588	539	530	530	–
Interest & Investment Income	2,331	2,099	1,696	1,201	1,070	781	854	660	21	20	21	15	8.00	4.00	4.00	3.00	5.00	21	–
Other Non-Operating Income	112	99	88	169	182	206	124	4.00	-208	-28	–	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	0	1,179	507	0	0	–	–	–	215	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	5,725	0	152	0	431	0	0	6,149	181	0	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-236	0	0	475	0	269	-205	-86	9.00	–	–	–	–	–	–	–	–	–	–
Legal Settlements	–	-100	0	-5,803	0	0	–	–	–	–	–	–	72	–	–	–	–	–	–
Pretax Income	2,136	6,148	11,173	5,836	10,537	9,770	8,997	1,406	8,268	8,637	8,616	7,678	7,528	6,305	5,747	5,601	5,900	5,537	4,359
Income Tax Expense	408	1,562	2,805	1,509	2,548	2,569	2,366	2,002	1,637	3,317	3,386	3,033	2,928	2,436	2,258	2,179	2,200	2,193	1,722
Income from Continuing Operations	–	–	–	4,149	7,910	7,188	6,629	-597	6,606	5,291	5,202	4,626	4,600	3,871	3,493	3,425	3,700	3,330	2,637
Income from Discontinued Operations	–	–	–	0	0	-9.00	0	0	-8.00	-1.00	9.00	-1.00	-8.00	-7.00	-31	2.00	-4.00	-132	0
Net Income incl. Noncontrolling Interests	1,728	4,586	8,368	4,327	7,989	7,192	6,631	-596	6,623	5,319	5,239	4,644	4,592	3,862	3,458	3,424	3,696	3,212	–
Minority Interest in Earnings	-40	-28	24	16	-12	13	-3.00	-2.00	1.00	2.00	2.00	0	0	-2.00	-4.00	-3.00	–	–	–
Net Income	1,768	4,614	8,344	4,311	8,001	7,179	6,634	-594	6,622	5,317	5,237	4,644	–	–	–	3,427	3,696	3,198	2,637
Net Income to Common	1,768	4,614	8,344	4,311	8,001	–	–	–	–	–	5,237	4,644	4,592	3,864	3,462	3,427	3,696	3,209	2,623
EPS (Basic)(per share)	1.40	3.67	6.49	3.29	6.07	5.48	5.10	-0.57	6.47	4.93	4.66	3.98	3.77	3.04	2.59	2.51	2.58	2.23	1.97
EPS (Diluted)(per share)	1.39	3.66	6.47	3.26	6.02	5.46	5.08	-0.57	6.44	4.90	4.63	3.96	3.74	3.02	2.57	2.49	2.55	2.18	1.92
Shares Outstanding (Basic, Weighted)(shares)	1,267	1,259	1,285	1,312	1,319	1,309	1,301	1,044	1,020	1,073	1,118	1,161	1,217	1,271	1,338	1,367	1,434	1,434	1,328
Shares Outstanding (Diluted, Weighted)(shares)	1,271	1,262	1,290	1,323	1,329	1,314	1,305	1,044	1,024	1,079	1,126	1,169	1,226	1,280	1,347	1,377	1,450	1,469	1,372
Dividend per Share(per share)	2.66	2.66	2.42	2.20	2.00	2.00	2.00	2.00	2.00	1.70	1.40	1.10	0.90	0.65	0.50	0.35	0.31	0.26	0.23
EBITDA	9,266	13,113	18,109	12,178	17,796	18,352	16,358	6,739	12,017	12,861	11,567	10,730	9,907	8,963	7,899	7,606	7,814	7,320	5,889
Net Interest Income	–	–	–	–	–	0	0	-536	0	-1,058	-838	-600	-509	-557	-584	-536	-525	-509	-435
Premiums Earned	134,751	122,896	99,192	85,330	76,132	69,364	63,122	8,184	3,558	–	–	–	–	–	–	–	–	–	–
Net Investment Income	2,233	2,153	1,153	838	1,199	798	1,011	660	21	20	–	–	–	–	–	–	–	–	–
Policyholder Benefits & Claims	125,538	115,121	86,247	71,073	64,188	55,679	52,529	6,594	2,810	2,179	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 44.5%
Operating margin: 2.0%
Net margin: 1.2%
Return on equity, FY2025: 2.3%

Financial strength

Current ratio: 0.87
Debt to equity: 0.77
Debt to assets: 24.2%
Cash to current liabilities: 13.0%

Valuation

P/E ratio: 24.6
Price to sales: 0.29
Price to book: 1.50
Dividend yield: 2.87%